Style | Citing Format |
---|---|
MLA | Valedi S, et al.. "Investigating the Effect of Eye Movement Desensitization and Reprocessing on Pain Intensity in Patients With Primary Dysmenorrhea: A Protocol for a Randomized Controlled Trial." Trials, vol. 20, no. 1, 2019, pp. -. |
APA | Valedi S, Alimoradi Z, Moradibaglooei M, Pakpour AH, Ranjbaran M, Chegini V (2019). Investigating the Effect of Eye Movement Desensitization and Reprocessing on Pain Intensity in Patients With Primary Dysmenorrhea: A Protocol for a Randomized Controlled Trial. Trials, 20(1), -. |
Chicago | Valedi S, Alimoradi Z, Moradibaglooei M, Pakpour AH, Ranjbaran M, Chegini V. "Investigating the Effect of Eye Movement Desensitization and Reprocessing on Pain Intensity in Patients With Primary Dysmenorrhea: A Protocol for a Randomized Controlled Trial." Trials 20, no. 1 (2019): -. |
Harvard | Valedi S et al. (2019) 'Investigating the Effect of Eye Movement Desensitization and Reprocessing on Pain Intensity in Patients With Primary Dysmenorrhea: A Protocol for a Randomized Controlled Trial', Trials, 20(1), pp. -. |
Vancouver | Valedi S, Alimoradi Z, Moradibaglooei M, Pakpour AH, Ranjbaran M, Chegini V. Investigating the Effect of Eye Movement Desensitization and Reprocessing on Pain Intensity in Patients With Primary Dysmenorrhea: A Protocol for a Randomized Controlled Trial. Trials. 2019;20(1):-. |
BibTex | @article{ author = {Valedi S and Alimoradi Z and Moradibaglooei M and Pakpour AH and Ranjbaran M and Chegini V}, title = {Investigating the Effect of Eye Movement Desensitization and Reprocessing on Pain Intensity in Patients With Primary Dysmenorrhea: A Protocol for a Randomized Controlled Trial}, journal = {Trials}, volume = {20}, number = {1}, pages = {-}, year = {2019} } |
RIS | TY - JOUR AU - Valedi S AU - Alimoradi Z AU - Moradibaglooei M AU - Pakpour AH AU - Ranjbaran M AU - Chegini V TI - Investigating the Effect of Eye Movement Desensitization and Reprocessing on Pain Intensity in Patients With Primary Dysmenorrhea: A Protocol for a Randomized Controlled Trial JO - Trials VL - 20 IS - 1 SP - EP - PY - 2019 ER - |